Bendamustine Hydrochloride

FDA Approved: * May 15, 2018
Pharm Company: * EAGLE PHARMS
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Bendamustine Hydrochloride Overview

Bendamustine HCl, sold under the brand name Treanda among others, is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's lymphoma.[2][3] It is given by injection into a vein.[2] Common side effects include low blood cell counts, fever, nausea, diarrhea, loss of appetite, cough, and rash.[2] Other severe side effects include allergic reactions and increased ris...

Read more Bendamustine Hydrochloride Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Bendamustine

Recent Bendamustine Hydrochloride Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Bendamustine Hydrochloride: (4 results)

Sorted by National Drug Code

• 42367-520 Bendamustine Hydrochloride 100 mg Intravenous Injection by Eagle Pharmaceuticals, Inc
• 42367-521 Belrapzo 100 mg Intravenous Injection by Eagle Pharmaceuticals, Inc
• 67457-325 Bendamustine Hydrochloride 25 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC
• 67457-326 Bendamustine Hydrochloride 100 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution by Mylan Institutional LLC

Other drugs which contain Bendamustine Hydrochloride or a similar ingredient: (2 results)

• BENDEKA Bendamustine Hydrochloride
• TREANDA Bendamustine Hydrochloride1 discussion

Related Bendamustine Hydrochloride Topics: